Compare NextEra Energy, Inc. (NEE) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NextEra Energy, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? NextEra Energy, Inc. trades at $85.68 (market cap $178.85B), while Zimmer Biomet Holdings Inc trades at $95.77 (market cap $18.55B). The key difference: NextEra Energy, Inc. is far larger — about 9.6× Zimmer Biomet Holdings Inc's market cap, and NextEra Energy, Inc. pays the higher dividend (2.91%). Which is the better fit depends on your goals.
| NEE | ZBH | |
|---|---|---|
Market Cap | $178.85B | $18.55B |
Sector | Utilities | Health |
52-Week High | $97.88 | $107.71 |
52-Week Low | $69.77 | $79.58 |
Enterprise Value | $286.18B | $25.61B |
Dividend Yield | 2.91% | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NextEra Energy (NEE) trades at $84.70, showing minimal daily movement. The stock exhibits a bearish technical signal despite recent earnings beats in Q1 and Q2 2026. Financially, the company maintains strong profitability with a 32.4% net income margin and benefits from growing electricity demand driven by AI data center expansion, as highlighted in recent partnerships like the $100 billion Kentucky data center project with Brookfield (The Motley Fool, 2026-07-29).
Outlook remains positive due to robust dividend payments and strategic positioning in AI power infrastructure, though risks include high capital expenditures and rising debt levels. Analyst consensus is bullish with a $100.40 price target, suggesting significant upside potential from current levels.
ZBH trades at $97.78, up 1.27% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported Q2 2026 EPS of $2.07, exceeding expectations, and raised its 2026 outlook. Revenue growth remains steady at 4.8% year-over-year, though net income margin has moderated from 2023 peaks. Analyst consensus is a 'Buy' with a $103.56 price target, indicating modest upside potential from current levels.
The stock offers a balanced risk-reward profile with solid fundamentals and positive momentum, but faces headwinds from margin pressure and rising debt levels. Investors should weigh the strong institutional support and consistent earnings performance against competitive pressures and macroeconomic uncertainties affecting the medtech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
